AZULFIDINE Side Effects

6795001-2 | Dementia, Yellow Skin
on Jun 14, 2010 Female patient from JAPAN , 79 years of age, was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?), yellow skin. Azulfidine dosage: 500 Mg, 2x/day.

6794775-4 | Condition Aggravated, Decreased Appetite, Mucous Membrane Disorder, Oral Candidiasis, Pancytopenia, Sepsis
Patient was taking Azulfidine (View Usage). Patient had the following side effects: condition aggravated, decreased appetite, mucous membrane disorder, oral candidiasis, pancytopenia, sepsis (What is sepsis?) on Jun 11, 2010 from JAPAN Additional patient health information: Male patient , weighting 131.4 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), insomnia, cough, gastric ulcer and. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with METHOTREXATE (10 Mg/day, 2x/week) (View Methotrexate Review and Methotrexate Label ), RISEDRONATE SODIUM HYDRATE (1 Tablet/day, Daily) (View Risedronate Sodium Hydrate Review and Risedronate Sodium Hydrate Label ), MYSLEE (5 Mg, 1x/day) (View Myslee Review and Myslee Label ), ONON (4 Tablet, 2x/day) (View Onon Review and Onon Label ), PREDNISOLONE (1 Tablet/day, Daily) (View Prednisolone Review and Prednisolone Label ), TAKEPRON (1 Tablet/day, Daily) (View Takepron Review and Takepron Label ), LAFUTIDINE (10 Mg/day, Daily) (View Lafutidine Review and Lafutidine Label ), ANTOBRON (Unk) (View Antobron Review and Antobron Label ). Patient was hospitalized.

6782339-8 | Cushingoid, Face Oedema, Oedema Peripheral
Adverse event was reported on Jun 10, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 1000 Mg Per Day) . Location: JAPAN , 55 years of age, After Azulfidine was administered, patient had the following side effects: cushingoid, face oedema, oedema peripheral. During the same period patient was treated with PREDNISOLONE (20 Mg Daily) (View Prednisolone Review and Prednisolone Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6779888-5 | Histiocytosis Haematophagic, Pancytopenia
on Jun 08, 2010 Female patient from JAPAN , 59 years of age, was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: histiocytosis haematophagic, pancytopenia. Azulfidine dosage: 1000mg/day.


6779840-X | Electrocardiogram Abnormal, Oedema, Tachycardia
on Jun 09, 2010 Female patient from GERMANY , 36 years of age, was treated with Azulfidine (View Usage). Patient had the following side effects: electrocardiogram abnormal, oedema, tachycardia. Azulfidine dosage: 1500mg Daily.

6773078-8 | Infection, Pancytopenia, Stomatitis
Patient was taking Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: infection (What is infection?), pancytopenia, stomatitis on Jun 07, 2010 from JAPAN Additional patient health information: Male patient , 85 years of age, . Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with METHOTREXATE (5 Mg, 1x/day) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6773011-9 | Interstitial Lung Disease, Lung Disorder, Respiratory Failure
Adverse event was reported on Jun 04, 2010 by a Male patient taking Azulfidine (View Usage) (Dosage: 500 Mg, 2x/day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastritis, atrial fibrillation (What is atrial fibrillation?), hypertension, cerebral infarction, diabetes mellitus, cardiac failure, dyslipidaemia and. Location: JAPAN , weighting 111.6 lb, Patient experienced the following unwanted or unexpected effects: interstitial lung disease, lung disorder, respiratory failure. During the same period patient was treated with RIMATIL (100 Mg, 2x/day) (View Rimatil Review and Rimatil Label ), PARIET (10 Mg, 1x/day) (View Pariet Review and Pariet Label ), DIGOSIN (0.125 Mg, 1x/day) (View Digosin Review and Digosin Label ), NU LOTAN (25 Mg, 1x/day) (View Nu Lotan Review and Nu Lotan Label ), ASPIRIN (100 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), AMARYL (1 Mg, 1x/day) (View Amaryl Review and Amaryl Label ), LASIX (10 Mg, 1x/day) (View Lasix Review and Lasix Label ), LIPITOR (10 Mg, 1x/day) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6768590-1 | Bone Marrow Failure, Hepatic Function Abnormal, Viral Infection
on Jun 02, 2010 Female patient from JAPAN , 52 years of age, weighting 99.21 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient had the following side effects: bone marrow failure, hepatic function abnormal, viral infection (What is viral infection?). Azulfidine dosage: 500 Mg, 2x/day. Patient was hospitalized.

6766284-X | Chest X-ray Abnormal, Corynebacterium Test Positive, Disseminated Intravascular Coagulation, Leukopenia, Oropharyngeal Pain, Pyrexia, Septic Shock
on May 31, 2010 Male patient from JAPAN , 78 years of age, weighting 132.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), gastric ulcer, cerebral infarction, hypertension and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: chest x-ray abnormal, corynebacterium test positive, disseminated intravascular coagulation, leukopenia, oropharyngeal pain, pyrexia, septic shock. Azulfidine dosage: 500 Mg Daily. During the same period patient was treated with ALENDRONATE SODIUM (Unk) (View Alendronate Sodium Review and Alendronate Sodium Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ), PREDONINE (Unk) (View Predonine Review and Predonine Label ), GLUFAST (View Glufast Review and Glufast Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CALBLOCK (Unk) (View Calblock Review and Calblock Label ).

6762558-7 | Infection, Pancytopenia, Stomatitis
Patient was taking Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), pancytopenia, stomatitis on May 26, 2010 from JAPAN Additional patient health information: Male patient , 85 years of age, . Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with METHOTREXATE (5 Mg, 1x/day) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6756900-0 | Basedow's Disease, Hepatic Function Abnormal
Adverse event was reported on May 24, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 500 Mg, 2x/day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 53 years of age, weighting 87.52 lb, Patient had the following side effects: basedow's disease, hepatic function abnormal. During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), RIMATIL (View Rimatil Review and Rimatil Label ). Patient was hospitalized and became disabled.

6751964-2 | Erythema, Nausea, Ocular Hyperaemia, Pyrexia, Swelling Face
on May 21, 2010 Female patient from JAPAN , 51 years of age, weighting 109.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: erythema, nausea (What is nausea?), ocular hyperaemia, pyrexia, swelling face. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with RIMATIL (Unk) (View Rimatil Review and Rimatil Label ), SELBEX (Unk) (View Selbex Review and Selbex Label ), MOBIC (Unk) (View Mobic Review and Mobic Label ).

6750047-5 | Pleural Effusion
on May 20, 2010 Female patient from JAPAN , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion. Azulfidine dosage: 250 Mg, 2x/day. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACTONEL (View Actonel Review and Actonel Label ). Patient was hospitalized.

6744499-4 | Hepatic Function Abnormal, Pancytopenia
Patient was taking Azulfidine (View Usage). Patient had the following side effects: hepatic function abnormal, pancytopenia on May 19, 2010 from JAPAN Additional patient health information: Female patient , 52 years of age, . Azulfidine dosage: .

6741318-7 | Disseminated Intravascular Coagulation, Leukopenia, Oropharyngeal Pain, Pyrexia, Septic Shock
Adverse event was reported on May 14, 2010 by a Male patient taking Azulfidine (View Usage) (Dosage: 500 Mg Daily) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), gastric ulcer, cerebral infarction, hypertension and. Location: JAPAN , 78 years of age, weighting 132.7 lb, After Azulfidine was administered, patient had the following side effects: disseminated intravascular coagulation, leukopenia, oropharyngeal pain, pyrexia, septic shock. During the same period patient was treated with ALENDRONATE SODIUM (Unk) (View Alendronate Sodium Review and Alendronate Sodium Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ), PREDONINE (Unk) (View Predonine Review and Predonine Label ), GLUFAST (View Glufast Review and Glufast Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CALBLOCK (Unk) (View Calblock Review and Calblock Label ).

6738620-1 | Eosinophil Percentage Increased, Pleural Effusion
on May 13, 2010 Female patient from JAPAN , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophil percentage increased, pleural effusion. Azulfidine dosage: 250 Mg, 2x/day. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACTONEL (View Actonel Review and Actonel Label ). Patient was hospitalized.

6738617-1 | Disseminated Intravascular Coagulation, Leukopenia, Oropharyngeal Pain, Pyrexia, Septic Shock
on May 14, 2010 Male patient from JAPAN , 78 years of age, weighting 132.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), gastric ulcer, cerebral infarction, hypertension and was treated with Azulfidine (View Usage). Patient had the following side effects: disseminated intravascular coagulation, leukopenia, oropharyngeal pain, pyrexia, septic shock. Azulfidine dosage: 500 Mg Daily. During the same period patient was treated with ALENDRONATE SODIUM (Unk) (View Alendronate Sodium Review and Alendronate Sodium Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ), PREDONINE (Unk) (View Predonine Review and Predonine Label ), GLUFAST (View Glufast Review and Glufast Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CALBLOCK (Unk) (View Calblock Review and Calblock Label ).

6731618-9 | Irritable Bowel Syndrome, Nausea
Patient was taking Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: irritable bowel syndrome (What is irritable bowel syndrome?), nausea (What is nausea?) on May 18, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 170.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: Bid Po.

6724540-5 | Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Blood Potassium Increased, Blood Pressure Decreased, Blood Urea Increased, Depressed Level Of Consciousness, Disseminated Intravascular Coagulation, Epstein-barr Virus Infection, Hepatic Enzyme Increased
Adverse event was reported on May 06, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 1000 Mg/day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 57 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood pressure decreased, blood urea increased, depressed level of consciousness, disseminated intravascular coagulation, epstein-barr virus infection, hepatic enzyme increased. During the same period patient was treated with RHEUMATREX (8 Mg/day Twice Daily On Wednesday And 4 Mg /day Once Daily On Thursday) (View Rheumatrex Review and Rheumatrex Label ), PREDNISOLONE (5 Mg, 2x/day) (View Prednisolone Review and Prednisolone Label ), RIMATIL (100 Mg, 3x/day) (View Rimatil Review and Rimatil Label ), BREDININ (100 Mg Once Daily On Wednesday Once A Week) (View Bredinin Review and Bredinin Label ), TAKEPRON (View Takepron Review and Takepron Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), LOXONIN (View Loxonin Review and Loxonin Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ).

6722678-X | Granulocytopenia, Pain, Pyrexia, Septic Shock
on Apr 29, 2010 Male patient from JAPAN , 77 years of age, weighting 88.18 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient had the following side effects: granulocytopenia, pain (What is pain?), pyrexia, septic shock. Azulfidine dosage: Unk. During the same period patient was treated with PREDNISOLONE (Twice Daily In The Morning And At Noon) (View Prednisolone Review and Prednisolone Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6715993-7 | Leukopenia
on Apr 26, 2010 Male patient from JAPAN , 78 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: leukopenia. Azulfidine dosage: 1000 Mg/day. During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), TAKEPRON (View Takepron Review and Takepron Label ), PREDONINE (View Predonine Review and Predonine Label ), GLUFAST (View Glufast Review and Glufast Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALBLOCK (View Calblock Review and Calblock Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ).

6715834-8 | Human Herpesvirus 6 Infection
Patient was taking Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: human herpesvirus 6 infection on Apr 27, 2010 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ATELEC (View Atelec Review and Atelec Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6709698-6 | Blood Creatinine Increased, Proteinuria
Adverse event was reported on Apr 22, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 1000 Mg, Weekly) . Location: GERMANY , 13 years of age, Patient had the following side effects: blood creatinine increased, proteinuria.

6707956-2 | Blood Lactate Dehydrogenase Increased, Disseminated Intravascular Coagulation, Epstein-barr Virus Infection, Hepatic Enzyme Increased, Lymphoma, Lymphoproliferative Disorder, Sepsis
on Apr 21, 2010 Female patient from JAPAN , 57 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: blood lactate dehydrogenase increased, disseminated intravascular coagulation, epstein-barr virus infection, hepatic enzyme increased, lymphoma (What is lymphoma?), lymphoproliferative disorder, sepsis (What is sepsis?). Azulfidine dosage: 1000 Mg/day. During the same period patient was treated with RHEUMATREX (8 Mg/day Twice Daily On Wednesday And 4 Mg /day Once Daily On Thursday) (View Rheumatrex Review and Rheumatrex Label ), PREDNISOLONE (5 Mg, 2x/day) (View Prednisolone Review and Prednisolone Label ), RIMATIL (100 Mg, 3x/day) (View Rimatil Review and Rimatil Label ), BREDININ (100 Mg Once Daily On Wednesday Once A Week) (View Bredinin Review and Bredinin Label ), TAKEPRON (View Takepron Review and Takepron Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), LOXONIN (View Loxonin Review and Loxonin Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ).

6707561-8 | Erythema, Nausea, Pyrexia, Swelling Face
on Apr 21, 2010 Female patient from JAPAN , 51 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, nausea (What is nausea?), pyrexia, swelling face. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with RIMATIL (View Rimatil Review and Rimatil Label ), SELBEX (View Selbex Review and Selbex Label ), MOBIC (View Mobic Review and Mobic Label ).

6698610-4 | Cytomegalovirus Test Positive, Epstein-barr Virus Antibody Positive, Infectious Mononucleosis, Lymphadenopathy, Lymphocyte Morphology Abnormal, Oropharyngeal Pain, Pyrexia, Rash
Patient was taking Azulfidine (View Usage). Patient had the following side effects: cytomegalovirus test positive, epstein-barr virus antibody positive, infectious mononucleosis (What is infectious mononucleosis?), lymphadenopathy, lymphocyte morphology abnormal, oropharyngeal pain, pyrexia, rash (What is rash?) on Apr 15, 2010 from JAPAN Additional patient health information: Female patient , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with RIMATIL (Unk) (View Rimatil Review and Rimatil Label ), MOBIC (1 Tablet Daily) (View Mobic Review and Mobic Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), SLOW K (Unk) (View Slow-k Review and Slow-k Label ), NORTRIPTYLINE HCL (Unk) (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), URSO 250 (Unk) (View Urso 250 Review and Urso 250 Label ), BIOFERMIN (Unk) (View Biofermin Review and Biofermin Label ), METHYCOBAL (Unk) (View Methycobal Review and Methycobal Label ).

6695940-7 | Deep Vein Thrombosis
Adverse event was reported on Apr 13, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 250 Mg Per Day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 74 years of age, After Azulfidine was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with ONE ALPHA (Unk) (View One-alpha Review and One-alpha Label ).

6689042-3 | Bronchiolitis, Eosinophilia
on Apr 08, 2010 Female patient from JAPAN , 59 years of age, weighting 117.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: bronchiolitis, eosinophilia. Azulfidine dosage: 500 Mg Daily. During the same period patient was treated with MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), FAMOGAST (Unk) (View Famogast Review and Famogast Label ), LIVALO (Unk) (View Livalo Review and Livalo Label ), MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), SLO BID (Unk) (View Slo-bid Review and Slo-bid Label ). Patient was hospitalized.

6682644-X | Pleural Effusion
on Apr 08, 2010 Female patient from JAPAN , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient had the following side effects: pleural effusion. Azulfidine dosage: Unk. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACTONEL (View Actonel Review and Actonel Label ). Patient was hospitalized.

6681726-6 | Colitis Ulcerative, Haemorrhage
Patient was taking Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: colitis ulcerative, haemorrhage on Apr 02, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 196.0 lb, was diagnosed with colitis ulcerative, diabetes mellitus, hypertension, gastrooesophageal reflux disease and. Azulfidine dosage: 1500 Mg, 3x/day. During the same period patient was treated with ACTOS (45 Mg, Unk) (View Actos Review and Actos Label ), MICARDIS (Unk) (View Micardis Review and Micardis Label ), PROTONIX (Unk) (View Protonix Review and Protonix Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ).

6680806-9 | Deep Vein Thrombosis
Adverse event was reported on Apr 02, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 250 Mg Per Day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 74 years of age, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with ONE ALPHA (Unk) (View One-alpha Review and One-alpha Label ).

6671599-X | Basedow's Disease, Hepatic Function Abnormal
on Mar 26, 2010 Female patient from JAPAN , 53 years of age, weighting 87.52 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient had the following side effects: basedow's disease, hepatic function abnormal. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), RIMATIL (View Rimatil Review and Rimatil Label ). Patient was hospitalized and became disabled.

6665857-2 | Chills, Cholangitis Sclerosing, Haemangioma Of Liver, Haematocrit Decreased, Haemoglobin Decreased, Headache, Hepatitis, Hyperhidrosis
on Mar 23, 2010 Female patient from UNITED STATES , weighting 313.1 lb, was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: chills, cholangitis sclerosing, haemangioma of liver, haematocrit decreased, haemoglobin decreased, headache (What is headache?), hepatitis (What is hepatitis?), hyperhidrosis. Azulfidine dosage: Unk. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), KLONOPIN (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

6665598-1 | Bronchiolitis, Eosinophilia
Patient was taking Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: bronchiolitis, eosinophilia on Mar 23, 2010 from JAPAN Additional patient health information: Female patient , 59 years of age, weighting 117.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 500 Mg Daily. During the same period patient was treated with MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), FAMOGAST (Unk) (View Famogast Review and Famogast Label ), LIVALO (Unk) (View Livalo Review and Livalo Label ), MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), SLO BID (Unk) (View Slo-bid Review and Slo-bid Label ). Patient was hospitalized.

6655985-X | Pneumonia
Adverse event was reported on Mar 17, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), interstitial lung disease and. Location: JAPAN , 63 years of age, Patient had the following side effects: pneumonia (What is pneumonia?). Patient was hospitalized.

6654024-4 | Pemphigus
on Mar 16, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: pemphigus (What is pemphigus?). Azulfidine dosage: Unk. During the same period patient was treated with TIOPRONIN (Unk) (View Tiopronin Review and Tiopronin Label ).

6633380-7 | Genital Herpes, Rheumatoid Arthritis, White Blood Cell Count Decreased
on Mar 02, 2010 Female patient from JAPAN , 72 years of age, weighting 149.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: genital herpes, rheumatoid arthritis (What is rheumatoid arthritis?), white blood cell count decreased. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with ETANERCEPT (25 Mg, Weekly) (View Etanercept Review and Etanercept Label ), METHOTREXATE (6 Mg, Weekly) (View Methotrexate Review and Methotrexate Label ).

6633169-9 | Cryptococcosis
Patient was taking Azulfidine (View Usage). Patient had the following side effects: cryptococcosis on Mar 03, 2010 from JAPAN Additional patient health information: Female patient , 76 years of age, . Azulfidine dosage: Unk. During the same period patient was treated with METHOTREXATE SODIUM (8mg/week) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ).

6628925-7 | Disseminated Intravascular Coagulation, Haematuria, Melaena, Multi-organ Failure, Oedema, Purpura
Adverse event was reported on Mar 02, 2010 by a Male patient taking Azulfidine (View Usage) (Dosage: 250mg Per Day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 66 years of age, After Azulfidine was administered, patient had the following side effects: disseminated intravascular coagulation, haematuria, melaena, multi-organ failure, oedema, purpura. Patient was hospitalized.

6616753-8 | Oral Pain, Trismus
on Feb 25, 2010 Male patient from JAPAN , 70 years of age, was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: oral pain, trismus. Azulfidine dosage: Unk.

6616609-0 | Bronchiolitis, Eosinophil Count Increased
on Feb 25, 2010 Female patient from JAPAN , 59 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient had the following side effects: bronchiolitis, eosinophil count increased. Azulfidine dosage: 1000mg/day. During the same period patient was treated with MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), FAMOGAST (Unk) (View Famogast Review and Famogast Label ), LIVALO (Unk) (View Livalo Review and Livalo Label ), MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), SLO BID (Unk) (View Slo-bid Review and Slo-bid Label ). Patient was hospitalized.

6596623-4 | Erythema Multiforme
Patient was taking Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: erythema multiforme on Feb 15, 2010 from GERMANY Additional patient health information: Female patient , 50 years of age, was diagnosed with spondyloarthropathy, sleep disorder (What is sleep disorder?), cough, oropharyngeal pain and. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with VALERIAN ROOT (2 Df, 1x/day) (View Valerian Root Review and Valerian Root Label ), MUCOSOLVAN (Unk) (View Mucosolvan Review and Mucosolvan Label ), TONSILGON (Unk) (View Tonsilgon Review and Tonsilgon Label ), DECORTIN (Unk) (View Decortin Review and Decortin Label ). Patient was hospitalized.

6594858-8 | Hepatic Function Abnormal
Adverse event was reported on Feb 15, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 53 years of age, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Patient was hospitalized.

6583719-6 | Abdominal Pain, Coagulopathy, Jaundice, Liver Transplant, Mental Status Changes
on Feb 13, 2010 Male patient from UNITED STATES , 46 years of age, weighting 295.4 lb, was treated with Azulfidine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), coagulopathy, jaundice (What is jaundice?), liver transplant (What is liver transplant?), mental status changes. Azulfidine dosage: Oral 047. Patient was hospitalized.

6575518-6 | Haematuria, Melaena, Oedema, Purpura
on Feb 03, 2010 Male patient from JAPAN , 66 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: haematuria, melaena, oedema, purpura. Azulfidine dosage: Unk. Patient was hospitalized.

6546680-6 | Febrile Neutropenia, Leukopenia
Patient was taking Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, leukopenia on Jan 20, 2010 from GERMANY Additional patient health information: Female patient , 78 years of age, weighting 136.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 900 Mg, 1x/day.

6543710-2 | Cardiomegaly, Pericardial Effusion
Adverse event was reported on Jan 19, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 2 G, 1x/day) was diagnosed with spinal osteoarthritis and. Location: GERMANY , 59 years of age, weighting 125.7 lb, Patient had the following side effects: cardiomegaly, pericardial effusion. During the same period patient was treated with ENBREL (1 X 25 Mg, Weekly) (View Enbrel Review and Enbrel Label ), HUMIRA (1 X 40 Mg/day, Every 2 Weeks) (View Humira Review and Humira Label ), REMICADE (1 X 200 Mg, Every 6 Weeks) (View Remicade Review and Remicade Label ), CELEBREX (View Celebrex Review and Celebrex Label ), CALCIMAGON (View Calcimagon Review and Calcimagon Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), ACTONEL (View Actonel Review and Actonel Label ).

6543188-9 | Muscle Spasms, Pyrexia
on Jan 07, 2010 Female patient from JAPAN , 45 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: muscle spasms, pyrexia. Azulfidine dosage: Unk. During the same period patient was treated with CELECOX (Unk) (View Celecox Review and Celecox Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), HYPEN (Unk) (View Hypen Review and Hypen Label ).

6536782-2 | Muscle Spasms, Pyrexia
on Dec 29, 2009 Female patient from JAPAN , 45 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms, pyrexia. Azulfidine dosage: Unk. During the same period patient was treated with CELECOX (Unk) (View Celecox Review and Celecox Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), HYPEN (Unk) (View Hypen Review and Hypen Label ).

6525928-8 | Blood Pressure Decreased, Dehydration, Diarrhoea, Poisoning, Vomiting, Weight Decreased
Patient was taking Azulfidine (View Usage). Patient had the following side effects: blood pressure decreased, dehydration, diarrhoea, poisoning (What is poisoning?), vomiting, weight decreased on Dec 21, 2009 from ARGENTINA Additional patient health information: Female patient , 61 years of age, was diagnosed with colitis ulcerative and. Azulfidine dosage: 500 Mg, 4x/day. During the same period patient was treated with LOPERAMIDE (Unk) (View Loperamide Review and Loperamide Label ), TEGRETOL (Unk) (View Tegretol Review and Tegretol Label ), TRYPTANOL (Unk) (View Tryptanol Review and Tryptanol Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.